Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: MSB0010841
Total 2 results
Merck KGaA, Darmstadt, Germany
Completed
Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects
Psoriasis
Germany
EMD Serono
Merck KGaA, Darmstadt, Germany
Terminated
MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma
Melanoma
United States
Sponsors and Collaborators
Marcus Vinícius Guimarães de Lacerda
Jia Liu
Only For Children Pharmaceuticals
Sahar Salehi
Klinikum Bad Woerishofen
Egyptian Russian University
The People's Hospital of Guangxi Zhang Autonomous Region
Van Boven, Robert W., M.D.
Genuv Inc.
Kerstyn C. Zalesin, M.D.
Friedrich Miescher Institute for Biomedical Research (FMI)
Pancreatic Cancer UK
Liming Cheng
Royal Hobart Hospital Research Foundation (funding source)
Kuwait University
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Hoersholm Hospital
Hopeful Aging
Xiao-Ming Mao
Biorobotic Institute Scuola Superiore sant'Anna Pisa
View Full List
Medical Conditions
Advanced Gastric Cancer With Serosal Invasion
EHMT1
Pancytopenia Due to Chemotherapy
Autologous Haematopoietic Stem Cell Transplant
Raynaud Secondary to Other Autoimmune Disease
Secondary Hypertension to Endocrine Disorders
Pulmonary Invasive Aspergillosis
High Perinatal Mortality
Airway Obstruction
Caffeine Dosage
Gait Variability; Elders; Fall; Re-education
Stereotype-threat
Enlarged Uterus
Smith-Lemli-Opitz Syndrome
Role of Vitamin D in IVF for Better Outcome
Global Health
Stage II Vulvar Cancer
Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Urinary Tract Carcinoma
Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
View Full List
Drug Interventions
Cetrorelix 78 mg + 78 mg
Flibanserin 100 mg dose every evening
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Ruxolitinib
Oxycodone, fentanyl
SERETIDE Diskus
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Indoximod
Polyethylene glycol 3350
Enzalutamide, Abiraterone
Bortezomib/dexamethasone
Cytarabine ARA-C
Lamivudine
Mupirocin Calcium
PF-00868554
Insulin
Topotecan
Epimedium Prenylflavonoids Extract
Methotrexate
Atezolizumab
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in Bulgaria
Contract Research Organizations in Chile
Contract Research Organizations in Egypt
Contract Research Organizations in Hong Kong
Contract Research Organizations in Ireland
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Myanmar
Contract Research Organizations in Netherlands
Contract Research Organizations in Poland
Contract Research Organizations in Suriname
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in France
Lonza
ADDS (Advanced Drug Development Services)
ICON
Advanced BioScience Laboratories
Axonal-Biostatem
NAMSA
OPIS
Firalis Molecular Precision
Ad Hoc Clinical
NDA Regulatory Science (NDA Group)
All CROs in France
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe